Successful Treatment of Aortic Thrombosis after Umbilical Catheterization with Low-Molecular-Weight Heparin.
- Author:
Shin Hye KIM
1
;
Kyu Hyung LEE
;
Young Sun WEE
;
Gae Hyun AHN
Author Information
1. Department of Pediatrics, Pochon CHA University, Sungnam, Korea. khlee45@yahoo.co.kr
- Publication Type:Case Report
- Keywords:
Aortic thrombosis;
Neonate;
Low-molecular-weight heparin
- MeSH:
Catheterization*;
Catheters*;
Child;
Heparin;
Heparin, Low-Molecular-Weight*;
Humans;
Infant, Newborn;
Thrombosis*;
Umbilical Cord
- From:Journal of the Korean Society of Neonatology
2007;14(1):93-97
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Aortic thrombosis is one of the common complications caused by umblical cord catheterization. There are three treatment options for aortic thrombosis:anticoagulation, thrombolysis, surgery. Low-molecular-weight heparin has several advantages over unfractionized heparin in the treatment of thrombosis. However, there is limited experience on using low-molecular-weight heparin in children, especially in the newborns. We experienced a case of aortic thrombosis caused by umbilical cord catheterization, which was successfully treated with low-molecular-weight heparin.
